Ebitda Cambio Fecha
Agios Pharmaceuticals USD -109.2M 540K 2026-06
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Arrowhead Research USD -147.68M 40.33M 2026-06
Astellas Pharma JPY 182.02B 53.22B 2026-09
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
BioMarin Pharmaceutical USD 54.32M 167.99M 2026-09
Celltrion KRW 25.72B 6.08B 2026-06
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Divis Laboratories Ltd INR 15.66B 3.04B 2026-09
Exelixis USD 275.36M 19.96M 2026-09
Halozyme Therapeutics USD 336.16M 7.34M 2026-09
Ionis Pharmaceuticals USD -95.22M 9.99M 2026-09
Kangmei Pharma CNY -12.72M 30.02M 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Moderna USD -687M 571M 2026-06
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Novartis USD 8.62B 2.14B 2026-09
Omeros USD -47.96M 7.39M 2023-09
OPKO Health USD 20.39M 48.2M 2026-06
Organigram Holdings CAD 15.45M 20.21M 2026-06
Pfizer USD 6.36B 350M 2026-09
Pharma Mar EUR 9.63M 8.93M 2026-09
PTC Therapeutics USD 161.9M 99.92M 2026-06
Qiagen NV USD 219.78M 12.13M 2026-09
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Sartorius EUR 279.9M 600K 2026-09
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Tilray USD 8.36M 1.82M 2025-09
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
Vertex Pharmaceuticals USD 888.6M 436.6M 2026-09
Zealand Pharma A/S -379M 348.47M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 419.24M 463.46M 2026-06